Quality of Glycemic Control: Assessment Using Relationships Between Metrics for Safety and Efficacy-Reference-Cited by-同舟云学术

Quality of Glycemic Control: Assessment Using Relationships Between Metrics for Safety and Efficacy

Published:2021-10-01 Issue:10 Volume:23 Page:692-704
ISSN:1520-9156
Container-title:Diabetes Technology & Therapeutics
language:en
Short-container-title:Diabetes Technology & Therapeutics

Author:

Rodbard David¹^ORCID

Affiliation:

1. Biomedical Informatics Consultants LLC, Clinical Biostatistics Department, Potomac, Maryland, USA.

Publisher

Mary Ann Liebert Inc

Subject

Medical Laboratory Technology,Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/dia.2021.0115

Reference48 articles.

1. 1. Rodbard D, Berger M, Pernick N: Computer, networking, and information systems to facilitate delivery of health care to patients with diabetes. In: Baba S, Kaneko T, eds. Diabetes 1994, Proceedings of the 15th International Diabetes Federation Congress, Kobe, November 6–11, 1994. Elsevier, Amsterdam, 1995, pp. 800–803.

2. A Review of Continuous Glucose Monitoring-Based Composite Metrics for Glycemic Control

3. Metrics to Evaluate Quality of Glycemic Control: Comparison of Time in Target, Hypoglycemic, and Hyperglycemic Ranges with “Risk Indices”

4. Metrics for glycaemic control — from HbA1c to continuous glucose monitoring

5. Glycaemic variability in diabetes: clinical and therapeutic implications

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Statistical Packages and Algorithms for the Analysis of Continuous Glucose Monitoring Data: A Systematic Review;Journal of Diabetes Science and Technology;2024-01-05

2. Comparison of Glycemia Risk Index with Time in Range for Assessing Glycemic Quality;Diabetes Technology & Therapeutics;2023-12-01

3. Glycemic variability: Measurement, target, impact on complications of diabetes and does it really matter?;Journal of Diabetes Investigation;2023-11-21

4. Association Between Continuous Glucose Monitoring-Derived Glycemia Risk Index and Albuminuria in Type 2 Diabetes;Diabetes Technology & Therapeutics;2023-10-01

5. Continuous Glucose Monitoring-Based Composite Metrics: A Review and Assessment of Performance in Recent-Onset and Long-Duration Type 1 Diabetes;Diabetes Technology & Therapeutics;2023-07-01